James Shehan, Former General Counsel at Novo Nordisk, Joins Lowenstein Sandler’s Life Sciences Practice

NEW YORK--()--Lowenstein Sandler LLP announced today that seasoned health care executive and lawyer James Shehan will join the firm as a senior counsel in its Life Sciences practice and as head of the Firm’s FDA Regulatory Practice. Mr. Shehan previously served for over 19 years as general counsel of Novo Nordisk and most recently was of counsel at Hyman, Phelps & McNamara, an FDA regulatory law boutique firm in Washington, D.C. Early in his career, Jim also worked as corporate counsel at Pfizer and at FDA.

“I’m excited to join my new Life Sciences colleagues at Lowenstein Sandler, who share my business-focused perspective on the industry and passion for helping clients bring new products to market. I admire the firm’s entrepreneurial approach and I share its enthusiasm to help clients innovate, develop, and commercialize lifesaving products.”

Mr. Shehan brings to Lowenstein vast experience with complex regulatory issues related to drug development and life cycle management, compliance matters, internal investigations, and transactions. He has worked extensively on life sciences mergers and acquisitions as well as licensing matters. With over three decades of life sciences experience, his extensive knowledge of industry issues extends beyond drugs and biologics to medical devices, cosmetics, foods and dietary supplements. Mr. Shehan also has a particularly deep understanding of the emerging field of biosimilars.

In his nearly 20 years at Novo Nordisk, the company became a market leader in diabetes products and grew sales from $100 million to more than $5.5 billion. Simultaneously, under Mr. Shehan’s stewardship, the company’s legal, compliance and government affairs staff grew to more than 100 personnel with a budget of more than $30 million.

Mr. Shehan said, “I’m excited to join my new Life Sciences colleagues at Lowenstein Sandler, who share my business-focused perspective on the industry and passion for helping clients bring new products to market. I admire the firm’s entrepreneurial approach and I share its enthusiasm to help clients innovate, develop, and commercialize lifesaving products.”

Michael J. Lerner, Chair of Lowenstein’s Life Sciences practice, said, “Jim’s impressive credentials will add value to our clients as we continue to expand our regulatory practice and provide counsel to companies on a wide variety of matters, including drug development and marketing, M&A, and compliance. His deep industry knowledge and extensive experience will enhance Lowenstein‘s longstanding work with emerging and established life sciences companies, investors, and investment banks.”

Mr. Shehan received his J.D. from the Georgetown University Law Center and his B.A. from Columbia University.

About Lowenstein Sandler

Lowenstein Sandler is a leading national law firm with offices in New York, California, Washington DC, New Jersey and Utah.

Recognized for the breadth and depth of its practice, its extraordinary client service and its entrepreneurial spirit, the firm provides seasoned, value-added legal advice and strategic solutions for its clients.

An AmLaw 200 firm, Lowenstein brings deep resources to its cases, but its size ensures a personal relationship with senior leadership that delivers results.

Lowenstein Sandler prides itself on being a different kind of law firm – one deeply rooted in the interests of its clients, colleagues and communities.

Contacts

Lowenstein Sandler
Chris Gale, (646) 695-2883

Recent Stories

RSS feed for Lowenstein Sandler LLP